Log in to save to my catalogue

Vitamin D Supplementation and Disease-Free Survival in Stage II Melanoma: A Randomized Placebo Contr...

Vitamin D Supplementation and Disease-Free Survival in Stage II Melanoma: A Randomized Placebo Contr...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8226808

Vitamin D Supplementation and Disease-Free Survival in Stage II Melanoma: A Randomized Placebo Controlled Trial

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Patients with newly resected stage II melanoma (n = 104) were randomized to receive adjuvant vitamin D3 (100,000 IU every 50 days) or placebo for 3 years to investigate vitamin D3 protective effects on developing a recurrent disease. Median age at diagnosis was 50 years, and 43% of the patients were female. Median serum 25-hydroxy vitamin D (25OHD)...

Alternative Titles

Full title

Vitamin D Supplementation and Disease-Free Survival in Stage II Melanoma: A Randomized Placebo Controlled Trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8226808

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8226808

Other Identifiers

ISSN

2072-6643

E-ISSN

2072-6643

DOI

10.3390/nu13061931

How to access this item